IBT Staff Reporter

118681-118710 (out of 154943)

RAM Energy lenders reaffirm borrowing base

Independent energy company RAM Energy Resources Inc on Monday said its commercial lenders reaffirmed its existing borrowing base of $175 million, following a scheduled semi-annual redetermination.

Thailand wins praise for AIDS vaccine trial

An experimental AIDS vaccine that appears to be the first to protect people was mired for years in controversy, and credit for its success must go to Thailand where the trial was conducted, experts said.

Ferrellgas Partners posts wider-than-expected Q4 loss

Ferrellgas Partners LP posted a wider-than-expected fourth-quarter loss on lower propane sales.For the fourth quarter ended July 31, the company posted a net loss of $34.7 million, or 51 cents a unit, compared with a loss of $38.4 million, or 61 cents a unit, a year ago.

U.S. commander offers options for Afghanistan

The commander of U.S. and NATO forces in Afghanistan planned to offer options for policymakers to try to stem Taliban gains, including sending up to 30,000 to 40,000 additional combat troops and trainers, according to defense and congressional officials.

Honduras resists pressure over ousted leader Zelaya

Honduras' de facto government on Monday resisted pressure from opponents and the international community over ousted President Manuel Zelaya, who for a week has been holed up inside the Brazilian embassy seeking a return to power.

Zumiez raises Q3 earnings outlook

Skate and snow-boarding inspired retailer Zumiez Inc lifted its third-quarter earnings outlook, citing better-than-planned sales and product margins.

Iran flexes muscle ahead of talks with major powers

Iran test-fired missiles on Monday which a commander said could reach any regional target, flexing its military muscle ahead of this week's crucial talks with major powers worried about Tehran's nuclear ambitions.

Covidien to buy Aspect Medical for about $210 mln

Medical products maker Covidien said it agreed to buy Aspect Medical Systems Inc in a deal valued at about $210 million to boost its product offerings and add Aspect's brain monitoring technology to its portfolio.

Oil trades near $66, eyeing dollar

Oil traded around $66 a barrel on Monday, steadying after an earlier decline which extended last week's 8.4 percent slide, as the U.S. dollar lost ground and stock markets moved higher.

Apple passes 2 billion app downloads

Apple Inc said on Monday that downloads from its iTunes applications store had passed 2 billion and that it now has more than 85,000 apps available for the iPhone and iPod Touch.

Abbott, Johnson & Johnson bulk up

U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday aimed at securing vaccines and other products key to future growth.

Paranormal Activity has cult potential

Hoping to catch lightning in a bottle (or the ghost in the machine), Paramount Pictures has been treading carefully with its release of Paranormal Activity, which opened in 12 theaters on Friday.

Cloudy again leads struggling box office

The family cartoon Cloudy With a Chance of Meatballs led the North American box office for a second weekend on Sunday while another slew of newcomers bombed amid crippling reviews and moviegoer apathy.

Wall Street to open higher with M&A boost

U.S. stocks were set for a higher open on Monday as more merger and acquisition activity and the last days of the third quarter encouraged investors following three sessions of losses.

Johnson & Johnson buys 18 pct stake in Crucell

U.S. diversified health care company Johnson & Johnson has bought an 18 percent stake in biotech firm Crucell for 302 million euros ($444 million) as part of a flu vaccine development deal, the Dutch company said on Monday.

Harrelson, Murray bring flair to Zombieland

Falling closer in tone to Shaun of the Dead than 28 Days Later or the George Romero movies, Zombieland has its tongue planted firmly in its rancid cheek while still delivering the visceral goodies.

Trauma stands out among new fall TV shows

NBC's primetime lineup is already laden with cop and hospital dramas, so it hardly seems necessary to add yet another to the schedule. And initially, the new medical series Trauma seems to be the same old tune, different verse.

Pages